Myotoxic effects of clenbuterol in the rat heart and soleus muscle

被引:62
作者
Burniston, JG
Ng, Y
Clark, WA
Colyer, J
Tan, LB
Goldspink, DF
机构
[1] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 2ET, Merseyside, England
[2] Univ Leeds, Dept Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Leeds, Dept Med, Leeds LS2 9JT, W Yorkshire, England
[4] Michael Reese Hosp & Med Ctr, Chicago, IL 60616 USA
关键词
anabolic adrenergic agonist; cardiomyocytes; sympathomimetic; necrosis; immunohistochemistry; beta-adrenergic antagonists;
D O I
10.1152/japplphysiol.00139.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Myocyte-specific necrosis in the heart and soleus muscle of adult male Wistar rats was investigated in response to a single subcutaneous injection of the anabolic beta(2)-adrenergic receptor agonist clenbuterol. Necrosis was immunohistochemically detected by administration of a myosin antibody 1 h before the clenbuterol challenge and quantified by using image analysis. Clenbuterol-induced myocyte necrosis occurred against a background of zero damage in control muscles. In the heart, the clenbuterol-induced necrosis was not uniform, being more abundant in the left subendocardium and peaking 2.4 mm from the apex. After position (2.4 mm from the apex), dose (5 mg clenbuterol/kg), and sampling time (12 h) were optimized, maximum cardiomyocyte necrosis was found to be 1.0 +/- 0.2%. In response to the same parameters (i.e., 5 mg of clenbuterol and sampled at 12 h), skeletal myocyte necrosis was 4.4 +/- 0.8% in the soleus. These data show significant myocyte-specific necrosis in the heart and skeletal muscle of the rat. Such irreversible damage in the heart suggests that clenbuterol may be damaging to long-term health.
引用
收藏
页码:1824 / 1832
页数:9
相关论文
共 39 条
[1]   Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibers [J].
Bakker, AJ ;
Head, SI ;
Wareham, AC ;
Stephenson, DG .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (06) :C1718-C1726
[2]   HETEROGENEOUS TRANSMURAL DISTRIBUTION OF BETA-ADRENERGIC-RECEPTOR SUBTYPES IN FAILING HUMAN HEARTS [J].
BEAU, SL ;
TOLLEY, TK ;
SAFFITZ, JE .
CIRCULATION, 1993, 88 (06) :2501-2509
[3]   ISOPROTERENOL-INDUCED MYOCARDIAL FIBROSIS IN RELATION TO MYOCYTE NECROSIS [J].
BENJAMIN, IJ ;
JALIL, JE ;
TAN, LB ;
CHO, K ;
WEBER, KT ;
CLARK, WA .
CIRCULATION RESEARCH, 1989, 65 (03) :657-670
[4]   Pharmacological treatment of cachexia: any progress? [J].
Bruera, E .
SUPPORTIVE CARE IN CANCER, 1998, 6 (02) :109-113
[5]   A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats [J].
Chen, KJD ;
Alway, SE .
JOURNAL OF APPLIED PHYSIOLOGY, 2000, 89 (02) :606-612
[6]   ANABOLIC EFFECTS OF CLENBUTEROL ON SKELETAL-MUSCLE ARE MEDIATED BY BETA(2)-ADRENOCEPTOR ACTIVATION [J].
CHOO, JJ ;
HORAN, MA ;
LITTLE, RA ;
ROTHWELL, NJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01) :E50-E56
[7]   Physiological cardiac reserve: development of a non-invasive method and first estimates in man [J].
Cooke, GA ;
Marshall, P ;
Al-Timman, JK ;
Wright, DJ ;
Riley, R ;
Hainsworth, R ;
Tan, LB .
HEART, 1998, 79 (03) :289-294
[8]  
DIMASSI N, 1992, CARDIOSCIENCE, V3, P7
[9]   The effects of the β2-agonist drug clenbuterol on taurine levels in heart and other tissues in the rat [J].
Doheny, MH ;
Waterfield, CJ ;
Timbrell, JA .
AMINO ACIDS, 1998, 15 (1-2) :13-25
[10]  
DUCHANIE D, 1992, UNDERGROUND STEROID